EMIS is a clinical software supplier to the UK healthcare market. The company was originally established to serve the GP market, where it has a dominant position with a market share of 56% of UK GP practices. It has expanded from this position to create a broad range of products serving the community, child and mental healthcare (CCMH) market, the acute sector, and community pharmacies (where it has c 37% share) as well specialist software and screening services for diabetic retinopathy. The company strategy is to provide connected healthcare solutions to facilitate patient-centric care.
In this video, CEO Andy Thorburn reviews the company’s FY17 results and discusses performance at a divisional level. He gives an update on the company’s recent customer support issues, including the potential financial impact, as well as outlining other short-term areas of focus. Finally, he discusses the current trading environment and gives his views on the company’s short and longer-term outlook.